# General Biotechnologies Company

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/general-biotechnologies-company

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Website: www.generalbiotechnologies.com
- Total disclosed funding: $0.3M
- Latest round: Seed (Sep 12, 2017)
- Investors on record: 2

## About

General Biotechnologies Company focuses on advancing biotechnological solutions, leveraging research and innovation to develop cutting-edge products in the life sciences sector.General Biotechnologies Company was founded in 2016 and is headquartered in Cambridge, US. The company specializes in biotechnological advancements and has made strategic pivots to enhance its product offerings. It raised USD 0.25 mn in Seed funding on September 12, 2017, from investors IndieBio and SOSV, marking its first significant funding round.General Biotechnologies Company specializes in developing biotechnological solutions aimed at improving life sciences applications. Their offerings focus on innovative research and the application of biotechnology in various sectors, though specific product details are not disclosed.The revenue model for General Biotechnologies Company is centered around the successful application of their biotechnological developments. Revenue is generated from clients engaging with their advanced solutions, though specific figures regarding revenue generation are not publicly disclosed.Looking ahead, General Biotechnologies Company intends to expand its portfolio with new product launches, although specific details and release dates are not mentioned. The company plans to explore new markets to reach a broader audience, utilizing the recent Seed funding of USD 0.25 mn to support research and development initiatives that align with these growth strategies.

## Funding rounds

- Seed, Sep 12, 2017, $0.3M — SOSV, IndieBio

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed
- IndieBio (https://capitalatlas.ai/funds/indiebio) — Seed